Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
Cadavid, Diego, Mellion, Michelle, Hupperts, Raymond, Edwards, Keith R, Calabresi, Peter A, Drulović, Jelena, Giovannoni, Gavin, Hartung, Hans-Peter, Arnold, Douglas L, Fisher, Elizabeth, Rudick, RichLanguage:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(19)30137-1
Date:
July, 2019
File:
PDF, 422 KB
english, 2019